Therefore, results of our study concur with previous findings in uveal melanoma and cutaneous melanoma that, suggested that loss of nuclear BAP1 protein expression correlated with an aggressive subtype with poor survival in OMM patients. The gene discussed is BAP1; the disease is uveal melanoma.